| 查看: 508 | 回复: 0 | |||
[交流]
请问慢乙肝的病人敢用苯溴马隆吗
|
|
如题,病人别嘌醇0.1 bid 后尿酸仍在五百多,现在建议苯溴马隆口服,但是查了资料说赛诺菲已经在03年因为苯溴马隆的肝损召回了,没有这方面的经验,请指教。 http://apps.who.int/medicinedocs/en/d/Js4947e/1.4.html 这是WHO的关于苯溴马隆召回的材料。 BENZ-BROMARONE - Withdrawn due to reports of liver damage France. Sanofi-Synthélabo has withdrawn its hyperuricaemic product benzbromarone (Desuric) in France following reports of serious liver damage associated with the product's use. Benzbromarone (Desuric) has been marketed in France since 1976, but rare reports of serious cytolytic liver damage, including fatal cases and others requiring liver transplants, have led to an unfavourable benefit/risk ratio. The company has therefore decided to stop the marketing of this product in France and to recall all stocks. Reference: Chaibriant H. Stop marketing of proprietary medical product DESURIC (Rm) (benzbromarone), 22 Apr 2003. Available from URL: http://agmed.sante.gouv.fr |
» 猜你喜欢
指南解读||《伏立康唑个体化用药指南》解读
已经有0人回复
伏立康唑对白血病患者化疗期间肺部侵袭性真菌感染的临床疗效与安全性评价
已经有0人回复
中医学论文润色/翻译怎么收费?
已经有283人回复
伏立康唑血药浓度影响因素探讨
已经有0人回复
国产伏立康唑对血液病患者预防真菌感染的疗效观察
已经有0人回复
伏立康唑对真菌感染的不同用药方法分析
已经有0人回复
中医334求调剂
已经有0人回复










回复此楼
100